granted
on 10 Dec 2023
Last Applicant/ Owned by
1150 Marina Village Parkway
Alameda
CA
94501
Serial Number
97473476 filed on 23rd Jun 2022
Registration Number
N/A
Correspondent Address
John Paul Oleksiuk
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"THERAPEUTICS"
"THERAPEUTICS" Color is not claimed as a feature of the mark. Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics, namely, diseases caused by genetic mutations and diseases and disorders for which gene modification would ameliorate or cure; Gene therapy products, namely, biologiRead More
Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics, namely, diseases caused by genetic mutations and diseases and disorders for which gene modification would ameliorate or cure; Gene therapy products, namely, biological preparations based on engineered cells for medical use for the treatment of diseases caused by genetic mutations and of diseases and disorders for which gene modification would ameliorate or cure related to immuno-oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics, namely, for the diagnosis, prevention, and treatment of diseases caused by genetic mutations and of diseases and disorders for which gene modification would ameliorate or cure; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, namely, neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, and pain, and also for the prevention and treatment of cardiovascular, peripheral nervous system, endocrine, gastrointestinal, renal, genetic immunological, hepatic, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, and hematologic diseases and disorders, and cance
No 97473476
No Service/Collective Mark
No 333322.20000
No
No
No
No
No
No
No
No
26.01.01 -
Circles as carriers or as single line borders
26.01.17 -
Two concentric circles
26.17.05 -
Horizontal line(s), band(s) or bar(s)
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
The mark consists of the stylized wordings "SCRIBE" above "THERAPEUTICS", all to the right of a stylized letter "X" partially formed by horizontal lines displayed atop a circle outline.
| Status Date | Action Taken |
|---|---|
| 12th Dec 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 10th Dec 2023 | SOU TEAS EXTENSION RECEIVED |
| 10th Dec 2023 | SOU EXTENSION 1 FILED |
| 10th Dec 2023 | SOU EXTENSION 1 GRANTED |
| 20th Jun 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 25th Apr 2023 | PUBLISHED FOR OPPOSITION |
| 25th Apr 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 05th Apr 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 16th Mar 2023 | EXAMINERS AMENDMENT -WRITTEN |
| 16th Mar 2023 | EXAMINERS AMENDMENT E-MAILED |
